Roche plans Phase 3 for its latest Alzheimer’s drug attempt after unveiling more early data
Roche on Thursday shared early positive results for its Alzheimer’s candidate trontinemab, the latest round of data in its ...
SHL Medical opens $220M SC factory, DHL acquires Cryopdp, AGC forms new division, new facilities for NBE, Siemens-Miko Ghana ...
There were nine PIPEs in the first quarter of 2025, compared to 34 in the same quarter of last year, according to data shared ...
FDA rejects Aldeyra's dry eye drug reproxalap again, seeks more data. Company plans 2025 resubmission. AbbVie partnership ...
What was once a promising area of cancer immunotherapy has had another late-stage failure. BeiGene said Thursday ...
MoonLake Immunotherapeutics gets $75M upfront from Hercules Capital in $500M financing deal; OSR Holdings to sell $80M in ...
Daymark Health launches with $11.5M from investors including Maverick Ventures and Yosemite to provide comprehensive care ...
FDA grants accelerated approval for Novartis's Vanrafia (atrasentan) for IgA nephropathy. The drug joins Tarpeyo and Filspari ...
Sarepta and Roche are hitting the brakes on three trials of their Duchenne gene therapy Elevidys in response to a request by the European Medicines Agency.
A few cell and gene therapy biotechs are doing alright this week. The latest is Neurona Therapeutics, which exclusively told ...
A rapid cascade of seemingly conflicting details from President Donald Trump’s tariff announcement left large drugmakers on ...
President Donald Trump on Wednesday announced broad global tariffs, including a 20% tariff on Europe, in a move that pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback